SynthesisJournal of orthopaedic surgery and research2025
High prevalence and multifactorial risks of sarcopenia in knee osteoarthritis: a systematic review and meta-analysis.
Synthesis in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reframing Nutraceuticals in Knee Osteoarthritis with Sarcopenia: A Muscle-Joint-Centered Narrative Review.Nutrients · 2026Review
- Association between sarcopenia and mortality in patients with osteoarthritis.Clinical rheumatology · 2026Article
- Beyond Histology: Tensiomyography as an Integrated Measure of Muscle Function in Osteoporotic and Osteoarthritic Patients.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the prevalence and risk factors of sarcopenia in patients with knee osteoarthritis (KOA) through a systematic review and meta-analysis.
methodsA comprehensive search was conducted in PubMed, Web of Science, Cochrane Library, Scopus, China National Knowledge Infrastructure, and WanFang databases for studies published between January 2000 and June 2025. Eligible studies were screened according to predefined inclusion and exclusion criteria. Data were extracted, study quality was assessed, and meta-analyses were performed using Stata 17.0.
resultsA total of 35 studies involving 13,528 KOA patients were included, of whom 3597 were diagnosed with sarcopenia. The pooled prevalence of sarcopenia and sarcopenic obesity was 25.07% (95% CI 18.85-31.29%) and 12.06% (95% CI 8.24-15.87%), respectively. Subgroup analyses revealed that sarcopenia prevalence increased with disease severity, reaching 26.01% (95% CI 16.27-35.75%) in patients with Kellgren-Lawrence grade 4 KOA. Prevalence was 25.65% (95% CI 20.30-31.00%) among female and 25.85% (95% CI 18.64-33.06%) among Asian populations. Among patients with osteoporosis and diabetes mellitus, prevalence rates were 21.68% (95% CI 8.84-34.53%) and 28.36% (95% CI 17.43-39.29%), respectively. Additionally, sarcopenia was more common among alcohol consumers (30.72%, 95% CI 15.58-45.86%) and smokers (29.82%, 95% CI 18.87-40.77%), with the prevalence being notably higher at 35.20% (95% CI 28.09-42.31%) among patients with irregular physical activity.
conclusionSarcopenia and sarcopenic obesity are highly prevalent in patients with KOA and are significantly associated with disease severity, gender, geographic region, comorbidities, and lifestyle factors. These findings highlight the clinical importance of assessing sarcopenia in KOA management. Early screening and timely interventions may improve patient outcomes and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.